Dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome 

NETHERLANDS – Dsm-Firmenich, innovators in nutrition, health, and beauty, has completed the acquisition of Adare Biome, a pioneer in the development and manufacturing of postbiotics. 

The deal was first announced on April 19, 2023, for an enterprise value of €275 million and represents an estimated 2023 EV/EBITDA multiple of 18x. 

Founded in 1907,  when French chemist Dr. Pierre Boucard launched Lactéol (a branded supplement for relieving gut upsets), Adare Biome’s has grown to become a major player in the postbiotics market.  

Lactéol is now available over the counter in 35 countries and is one of the most scientifically well-documented microorganism-based therapeutics in the world in terms of efficacy and safety. 

Unlike the live bacteria in probiotics, postbiotics consist of inanimate microorganisms and/or their cellular components and metabolites that confer a health benefit to the host.  

A growing body of scientific evidence shows that postbiotics deliver comparable health benefits and are more stable so have a longer shelf-life and can be used in a wider range of applications and in new ingredient combinations. 

Due to their health benefits, postbiotics is a rapidly emerging segment of the gut health market that is projected to grow strongly. 

DSM anticipates being able to rapidly extend the availability of Adare Biome’s Lactéol® for people through its B2C unit, i-Health.  

Additionally further development of the postbiotic B2B ingredient will include further science development and developing opportunities in dietary supplements, early life nutrition, medical nutrition, and nutritional improvement for the under-nourished.  

Adare Biome would also help establish DSM as a frontrunner in the growing microbiome management market for pets and expand its animal health range, where the stability of postbiotics means they can be incorporated into DSM’s premix feed solutions. 

For all the latest food industry news from Africa and the World, subscribe to our NEWSLETTER, follow us on Twitter and LinkedIn, like us on Facebook and subscribe to our YouTube channel.